Top news of the week: 11.01.2023.
The Top New York Biopharma Companies Hiring Now
There are plenty of options if you're looking to make a career move into Pharm Country. To help, here are some of the top biopharma companies hiring right now for positions based in New ...
Executives Reunite at JPM as Biotech Kicks Off 2023
JP Morgan week is shaping up to approximate pre-pandemic attendance levels as executives return to San Francisco after two years of COVID-19-enforced absences.
A flurry of pharma acquisitions kick off JPM week after a slow year for deals
Four life science companies have announced acquisitions worth roughly $4.5 billion in total, raising hopes that 2023 will yield more M&A.
AbbVie, Anima Biotech announce collaboration worth $580M plus
AbbVie and Anima Biotech announce collaboration in a deal worth up to over $580 million to modulate mRNA biology for three targets
Beyond Biotech podcast 28: Mainz Biomed, Newron Pharmaceuticals
This week, we have two guests. We have conversations with Newron CEO, Stefan Weber, and Mainz Biomed CEO, Guido Bächler.
Anima follows Takeda, Lilly deals with $580M Abbvie pact as Lightning strikes thrice
Since the advent of COVID-19 mRNA vaccines, the space has steadily grown hotter, a situation on which Anima Biotech Inc. has capitalized by way of a potential $580 million-plus deal with ...
Fate Uncertain As Cell Therapy Biotech Pulls Out Of J&J Deal, Restructures
<p>The company is discontinuing its lead clinical programs and planning major layoffs as it seeks to reprioritize its pipeline and extend cash runway. </p>
Executives On The Move: Aadi Bioscience, Viatris and More
<p><span style="color: black;">Recent executive moves in the industry include C-suite changes at Aadi Bioscience and Simcere Pharmaceutical. Meanwhile, new directors were appointed at ...